Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism.
Andreadou I, Mikros E, Ioannidis K, Sigala F, Naka K, Kostidis S, Farmakis D, Tenta R, Kavantzas N, Bibli SI, Gikas E, Skaltsounis L, Kremastinos DT, Iliodromitis EK.
Andreadou I, et al. Among authors: mikros e.
J Mol Cell Cardiol. 2014 Apr;69:4-16. doi: 10.1016/j.yjmcc.2014.01.007. Epub 2014 Jan 28.
J Mol Cell Cardiol. 2014.
PMID: 24486195